These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16684946)

  • 1. Torsades de pointes associated with ziprasidone.
    Heinrich TW; Biblo LA; Schneider J
    Psychosomatics; 2006; 47(3):264-8. PubMed ID: 16684946
    [No Abstract]   [Full Text] [Related]  

  • 2. [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
    Finzel M; Fric M; Laux G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S178-80. PubMed ID: 15570546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
    Kelly DL; Love RC
    Psychopharmacol Bull; 2001; 35(4):66-79. PubMed ID: 12397857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.
    Manini AF; Raspberry D; Hoffman RS; Nelson LS
    J Med Toxicol; 2007 Dec; 3(4):178-81. PubMed ID: 18072173
    [No Abstract]   [Full Text] [Related]  

  • 5. Antipsychotic medications and cardiac conduction risks.
    Roman M; Farmer SY
    Issues Ment Health Nurs; 2010 Jan; 31(1):68-70. PubMed ID: 19951166
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulpiride-associated torsade de pointes in a woman with bipolar disorder.
    Teng PR; Shen TY; Lai TJ
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):246. PubMed ID: 22443253
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with ziprasidone.
    Patel NC; Sierk P; Dorson PG; Crismon L
    J Am Acad Child Adolesc Psychiatry; 2002 May; 41(5):495. PubMed ID: 12014778
    [No Abstract]   [Full Text] [Related]  

  • 8. Torsade de pointes after ziprasidone overdose with coingestants.
    Alipour A; Cruz R; Lott RS
    J Clin Psychopharmacol; 2010 Feb; 30(1):76-7. PubMed ID: 20075653
    [No Abstract]   [Full Text] [Related]  

  • 9. The safety of atypical antipsychotics: does QTc provide all the answers?
    Nielsen J
    Expert Opin Drug Saf; 2011 May; 10(3):341-4. PubMed ID: 21504386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic changes with ziprasidone.
    Loebel A; Miceli J; Chappell P; Siu C
    J Am Acad Child Adolesc Psychiatry; 2006 Jun; 45(6):636-637. PubMed ID: 16721311
    [No Abstract]   [Full Text] [Related]  

  • 11. Ziprasidone in the management of schizophrenia : the QT interval issue in context.
    Taylor D
    CNS Drugs; 2003; 17(6):423-30. PubMed ID: 12697001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT interval duration and dispersion in children and adolescents treated with ziprasidone.
    Correll CU; Lops JD; Figen V; Malhotra AK; Kane JM; Manu P
    J Clin Psychiatry; 2011 Jun; 72(6):854-60. PubMed ID: 21457682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
    Minov C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for successful clinical management of schizophrenia with ziprasidone.
    Fagiolini A; Cañas F; Gallhofer B; Larmo I; Levy P; Montes JM; Papageorgiou G; Zink M; Rossi A
    Expert Opin Pharmacother; 2010 Sep; 11(13):2199-220. PubMed ID: 20658947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
    Greco KE; Tune LE; Brown FW; Van Horn WA
    J Clin Psychiatry; 2005 Jul; 66(7):928-9. PubMed ID: 16013910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose ziprasidone associated with QT interval prolongation.
    Witsil JC; Zell-Kanter M; Mycyk MB
    Am J Emerg Med; 2012 Jun; 30(5):837.e1-2. PubMed ID: 21641143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziprasidone induced symptomatic bradycardia: a case report.
    Menon V; Kattimani S; Ayyanar S
    Aust N Z J Psychiatry; 2011 Sep; 45(9):789. PubMed ID: 21668298
    [No Abstract]   [Full Text] [Related]  

  • 18. Ziprasidone for sedation of the agitated ED patient.
    Martel ML
    Am J Emerg Med; 2004 May; 22(3):238. PubMed ID: 15138973
    [No Abstract]   [Full Text] [Related]  

  • 19. Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.
    Snarr BS; Phan SV; Garner A; VandenBerg AM; Barth KS
    Ann Pharmacother; 2010 Apr; 44(4):760-3. PubMed ID: 20215494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine.
    Mittal SR
    J Assoc Physicians India; 2014 May; 62(5):426-7. PubMed ID: 25438492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.